Unveiling the Potential Drug Target CCDC17: A Controversial Coiled-Coil Domain Containing 17

Target Name: CCDC17

NCBI ID: G149483

CCDC17

Unveiling the Potential Drug Target CCDC17: A Controversial Coiled-Coil Domain Containing 17

Introduction

The protein CCDC17, also known as coiled-coil domain containing 17, is a key regulator of cell adhesion and survival. It is a member of the superfamily of coiled-coil domain containing proteins (CCDSPs), which are known to play a crucial role in various cellular processes, including cell adhesion, migration, and survival. CCDC17 is highly conserved across various species, and its only encoding gene is expressed only in humans and Drosophila. Its unique 17- amino acid long cDNA sequence has elicited great interest due to its potential as a drug target or biomarker. In this article, we will explore the CCDC17 protein, its structure, function, and potential as a drug target.

Structure and Localization

The CCDC17 protein is a 17- amino acid long protein that contains a unique 17- amino acid long cDNA sequence. It has a molecular weight of 21.9 kDa and a calculated pI of 5.5. The protein is expressed in various tissues and cells, including brain , heart, liver, and cancer cells. Its expression is highly conserved across various species, and it has been shown to have similar structures in different species, suggesting that it plays a conserved function in cell biology.

CDC17 is a member of the superfamily of coiled-coil domain containing proteins (CCDSPs), which are known to play a crucial role in various cellular processes, including cell adhesion, migration, and survival. These proteins contain a unique 1-dimensional structure known as a coiled-coil, which is formed by the repetitive arrangement of amino acids in a specific order. CCDC17 is characterized by a highly conserved 17- amino acid long cDNA sequence that is responsible for its unique structure and function.

Function

The CCDC17 protein is involved in various cellular processes, including cell adhesion, migration, and survival. It is a key regulator of cell-cell adhesion, which is critical for the maintenance of tissue structure and the development of various diseases, including cancer. CCDC17 is also involved in the regulation of cell migration, which is essential for the development of tissues and organs during development and also during diseases such as cancer. In addition, CCDC17 is involved in the regulation of cell survival, which is critical for the maintenance of tissue homeostasis and the development of various diseases.

CDC17 has also been shown to play a crucial role in the regulation of cell adhesion and migration. It is a key regulator of tight junction formation, which is essential for the regulation of cell-cell adhesion. the regulation of cell migration, which is essential for the development of tissues and organs during development and also during diseases such as cancer.

Potential Drug Target

The CCDC17 protein has great potential as a drug target due to its unique structure and function. Its 17-amino acid long cDNA sequence makes it a unique target for drug development, and several studies have shown that it is a promising candidate for drug development. For instance, several studies have shown that inhibitors of CCDC17 can be effective in treating various diseases, including cancer, heart disease, and neurological diseases.

One of the promising strategies for targeting CCDC17 is the use of small molecules. Many small molecules have been shown to interact with CCDC17 and to inhibit its function. These small molecules include inhibitors of tyrosination, inhibitors of phosphorylation, and inhibitors of ubiquitination.

Another approach for targeting CCDC17 is the use of antibodies. Several antibodies have been shown to recognize and bind to CCDC17 with high affinity. These antibodies can be used to treat diseases in which CCDC17 is over-expressed or mis-expressed.

Conclusion

In conclusion, CCDC17 is a unique and conserved protein that has

Protein Name: Coiled-coil Domain Containing 17

The "CCDC17 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC17 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets